Skip to main content

NCBiotech News

  • Three women from the North Carolina Biotechnology Center have been selected from among several thousand nominees as 2011 winners of Business Leader Media’s 10th Annual Women Extraordinaire Awards, which honor top women business leaders of the South.
  •  
  • A visiting scientist who recently joined the David H. Murdock Research Institute  in Kannapolis has landed a $100,000 grant to help him develop a technique using beneficial ingredients found in yogurt to overcome vitamin deficiencies in developing countries.
  • Upcoming Conference: 
  • Perhaps hungry young life-science companies could learn from people suffering from more basic forms of hunger: sometimes the help of a non-profit can be a life saver. Too often, non-profits are not among the bright blips on entrepreneurs’ funding- source radar. And in an era of angel and venture paucity, specialized foundation grants might be the ticket to improved prosperity – especially in health-care discoveries.
  • The ribbon cutting at Medicago's grand opening ceremony in Research Triangle Park. See photos from the event on our Facebook page
  • Opportunity for Science Teachers grades 7-12
  • Upcoming Webinars: 
  • N.C. Treasurer Janet Cowell unveils fund at SEBIO Investor Forum
  • SEBIO is all about bringing investment to life science in the southeast, and who better to tell the story of success than three previous showcase companies. Liquidia, Metabolon and Viamet took the stage Wednesday after lunch. They discussed the differences between their companies and one that pursues a single therapy. The people most aware of those differences are the investors who fund these companies.
  • If you have any special funding request searches, please feel free to send them any time (julie_king@ncbiotech.org). Please also advise if any of your partners have submitted grant applications to funding announcements posted in the weekly grant alert emails. We would love to hear of their successes!
  • Anthony Atala, M.D. Dogs, cats, horses and other animals may get a new lease on life and health, while also helping in the development of human therapies.
  • Time for discount pricing is running out fast if you’re planning to attend the 13th annual Southeast BIO Investor Forum November 2 to 3 at the Washington Duke Inn & Golf Club in Durham. The regular registration fee of $600 expires at the end of business October 28, 2011, leaving the only other option a $700 sign-up at the door. Life-science companies seeking investment partners have found this annual event a prime opportunity to connect with them – and to rub elbows and share ideas with hundreds of other attendees.
  • Biotechnology touches virtually every aspect of contemporary life, from food and clothing to health, environmental protection and transportation. No wonder, then, that it’s also a focus of scrutiny as scientists continue to tweak cells in ways that open new challenges and opportunities to mankind. If we are suddenly able to do something never before possible, does that mean we should?
  • Ridge Diagnostics is a 4-year-old San Diego medical diagnostics company with a growing lab in Research Triangle Park and a significant new product: the first reliable blood test for serious depression. Its proprietary MDDScore is a measurement of changes in 10 cellular markers in the blood. The system runs the data through an algorithm that assesses four different body systems to compute the final score—a number from one to nine.
  • John L. Atkins III, FAIA
  • Scientists studying the cancer-fighting potential of chemicals derived from broccoli and related plants may get a boost from an agreement recently signed by two North Carolina companies with a partner in England. Lalilab, of Durham, and PharmAgra Labs, of Brevard, have licensed a co-developed compound called Sulforadex to a 3-year-old British company, Evgen, for pharmaceutical development of their patented stabilized sulforaphane technology.
  • Research Triangle Park-based medical diagnostics company BioMedomics has added a new $745,000 federal grant to its war chest. BioMedomics, started in 2007 with the help of a $25,000 loan from the North Carolina Biotechnology Center, was awarded a two-year Small Business Innovation Research (SBIR) Phase II contract from the National Institutes of Health, to develop its portable system for detecting drug abuse.
  • Durham gastrointestinal drug development company Tranzyme Pharma has hired Gilead Sciences executive Franck Rousseau, M.D., to the newly created position of chief medical officer. More Durham medical device company Chesson Labs has raised $1.45 million of a $2 million goal in a second round of financing as it expands sales of Novaderm and Nuvavet, a liquid bandage product for human and veterinary use, respectively.

Pages

Subscribe to News & Events